Company facts
- Industry
- Laboratory Analytical Instruments
- Headquarters
- Seattle, Washington
- Most recent report
- 8-K, filed Sep 11, 2026
- Filings on record
- 325 filings
- On EDGAR
- CIK 1808805
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 25
News 8 of 42
Prospectuses and Registrations 8 of 32
- 424B5 Prospectus supplement for an offering Sep 18, 2026
- S-3 Shelf registration statement Sep 11, 2026
- S-8 Registration statement for an employee plan Feb 26, 2026
- S-8 Registration statement for an employee plan Feb 27, 2025
- 424B5 Prospectus supplement for an offering Mar 6, 2024
- S-3 Shelf registration statement Feb 28, 2024
- S-8 Registration statement for an employee plan Feb 28, 2024
- 424B3 Prospectus supplement for an offering Nov 22, 2023
Proxies 8 of 10
- DEFA14A Extra proxy material Apr 28, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2026
- DEFA14A Extra proxy material Apr 29, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2025
- DEFA14A Extra proxy material Apr 26, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
- DEFA14A Extra proxy material Apr 27, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 27, 2023
Ownership 8 of 179
- SCHEDULE 13D/A Large holder reported an active stake, amended Sep 11, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Aug 28, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Aug 14, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Jun 30, 2026
- 4 Insider reported a trade Jun 22, 2026
- 4 Insider reported a trade Jun 22, 2026
- 4 Insider reported a trade Jun 22, 2026
- 4 Insider reported a trade Jun 22, 2026
Other 8 of 37
- EFFECT Notice that a registration became effective Sep 18, 2026
- ARS Annual report sent to shareholders Apr 28, 2026
- ARS Annual report sent to shareholders Apr 29, 2025
- ARS Annual report sent to shareholders Apr 26, 2024
- EFFECT Notice that a registration became effective Mar 6, 2024
- CORRESP Reply to SEC staff Mar 4, 2024
- UPLOAD Comment letter from SEC staff Mar 4, 2024
- ARS Annual report sent to shareholders Apr 27, 2023
Everything here comes from Nautilus Biotechnology, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.